We are encoding the world’s digital information into DNA—fitting entire data centers into the palm of your hand. What CATALOG is building can be thought of as a printing press with movable typefaces. Instead of having to synthesize billions of different molecules, we are creating the necessary diversity by moving around the typefaces in different combinations.

AnimalBiome creates microbiome-based therapeutics to treat the more than nine million cats and dogs in the U.S. living with chronic digestive disorders. We have developed a process for creating a fecal microbiota transplant pill that is stable at room temperature and highly effective.

Tidal Vision is the only commercial scale US-based manufacturer of chitosan, a non-toxic, non-hazmat, biodegradable and market-proven industrial biopolymer extracted from crab shells. Tidal Vision’s zero-waste chitosan extraction process produces by far the most consistent quality and lowest cost chitosan in the industry. Tidal Vision converts chitosan from different into ready-to-use formulas that are optimized for industrial applications.

Mendel is a hybrid intelligent engine (human/AI) that can collect a patient’s medical records and combine it with the genetic profile of his or her cancer to find personalized meds that are still in the trial phase. It can also pair a patient with oncologists with a track record matching the patient’s case for a second opinion. Mendel’s business model is free for patients, including the 56% of cancer patients outside the U.S. and Europe.

BioInspira provides an emissions monitoring service for the industry. Our solution is composed of hardware-enabled software, including sensors that monitor components/facilities on a real-time basis—significantly reducing the rate of false positives and cutting down on maintenance. We also offer communication networks that provide remote monitoring capabilities and a data analytics and geospatial platform that provides actionable and intuitive insights to customers.

A2A Pharmaceuticals has designed new drug candidates for cancers like Leukemia and other life threatening diseases. A2A’s technology platform optimizes the efficacy of such options while minimizing toxicity much faster and more precisely than competitors. We build and evaluate small molecule libraries that consist of thousands to millions of members until we obtain candidates with optimal properties and matches.

Protera Biosciences is advancing the science of protein engineering to address critical challenges in food, agriculture, the environment, and human health. We’re optimizing the full protein engineering process, from design to testing and development.

Ria Health is a tech-enabled telehealth medical practice that provides evidence-based treatment for Alcohol Use Disorder (AUD).

Our Physician managed program includes Medication Assisted Treatment (MAT), digital tools for tracking progress, harm reduction, peer support and one on one coaching all done through the convenience of telehealth.

Our members have embraced our engaging program and achieved breakthrough outcomes in reducing their drinking and staying active and engaged to make meaningful behavioral change.

We work with health plans, self-insured employers and health systems to provide a treatment option that is effective, convenient and affordable.
For more information visit www.riahealth.com.

NeuroQore is comprised of a team of passionate and motivated scientists, engineers, and clinicians dedicated to developing pioneering neuromodulation treatments for various neurobehavioral conditions. We collaborate with world-class universities and research clinics to investigate ways to transform lives. At NeuroQore, we strive to create a world with effective solutions to devastating disorders: major depressive disorder and suicidality.